Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bhanji

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2022
Association between gut colonization of vancomycin-resistant enterococci and liver transplant outcomesDiana Chiang, Tanis C Dingle, Sara Belga, et al.
Alimentary Pharmacology & Therapeutics|February 5, 2019
The evolution and impact of sarcopenia pre- and post-liver transplantationRahima A Bhanji, Naoki Takahashi, Michael R Moynagh, et al.
Canadian Liver Journal|December 25, 2023
Post-transplant diabetes mellitus in Canadian liver and renal transplant recipientsRoman Dascal, Chris Wiebe, Mina Niazi, et al.
ACG Case Reports Journal|February 16, 2026
Treatment of Steroid-Refractory Immune Checkpoint-Related Hepatitis With RuxolitinibVivian V Nguyen, Malcolm Wells, Carlos Moctezuma-Velazquez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 27, 2018
Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver DiseaseRahima A Bhanji, Praveena Narayanan, Michael R Moynagh, et al.
Cells|April 23, 2022
Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with CirrhosisMaryam Ebadi, Cynthia Tsien, Rahima A Bhanji, et al.
Cells|April 12, 2022
Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential InterventionsMaryam Ebadi, Cynthia Tsien, Rahima A Bhanji, et al.
Journal of the Canadian Association of Gastroenterology|February 4, 2022
Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre CohortMatthew K Smith, Yin Chan, Aleksi E Suo, et al.
Canadian Liver Journal|December 25, 2023
COVID-19 infection in liver transplant recipients: Clinical features and outcomes from a Canadian multicentre cohortMatthew K Smith, Jessica Chow, Ruiyao Huang, et al.
Digestive Diseases and Sciences|March 24, 2018
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune HepatitisCumali Efe, Haider Al Taii, Henriette Ytting, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2022
Association between gut colonization of vancomycin-resistant enterococci and liver transplant outcomesDiana Chiang, Tanis C Dingle, Sara Belga, et al.
Alimentary Pharmacology & Therapeutics|February 5, 2019
The evolution and impact of sarcopenia pre- and post-liver transplantationRahima A Bhanji, Naoki Takahashi, Michael R Moynagh, et al.
Canadian Liver Journal|December 25, 2023
Post-transplant diabetes mellitus in Canadian liver and renal transplant recipientsRoman Dascal, Chris Wiebe, Mina Niazi, et al.
ACG Case Reports Journal|February 16, 2026
Treatment of Steroid-Refractory Immune Checkpoint-Related Hepatitis With RuxolitinibVivian V Nguyen, Malcolm Wells, Carlos Moctezuma-Velazquez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 27, 2018
Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver DiseaseRahima A Bhanji, Praveena Narayanan, Michael R Moynagh, et al.
Cells|April 23, 2022
Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with CirrhosisMaryam Ebadi, Cynthia Tsien, Rahima A Bhanji, et al.
Cells|April 12, 2022
Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential InterventionsMaryam Ebadi, Cynthia Tsien, Rahima A Bhanji, et al.
Journal of the Canadian Association of Gastroenterology|February 4, 2022
Clinical Course and Treatment Implications of Combination Immune Checkpoint Inhibitor-Mediated Hepatitis: A Multicentre CohortMatthew K Smith, Yin Chan, Aleksi E Suo, et al.
Canadian Liver Journal|December 25, 2023
COVID-19 infection in liver transplant recipients: Clinical features and outcomes from a Canadian multicentre cohortMatthew K Smith, Jessica Chow, Ruiyao Huang, et al.
Digestive Diseases and Sciences|March 24, 2018
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune HepatitisCumali Efe, Haider Al Taii, Henriette Ytting, et al.
Pageof 6